Ocumetics Technology Corp.
Ocumetics Technology Corp.
Your view on OTCFF
Overview
What the company does, where it operates, and who runs it.
About Ocumetics Technology Corp.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Dean E. Burns
- Headquarters
- 639-5th Avenue SW, Calgary, AB, CA
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- CEO
- Dean E. Burns
- Headquarters
- 639-5th Avenue SW, Calgary, AB, CA
Ocumetics Technology Corp., a research and product development company, designs and produces various lenses. Its products include Bionic Lens, an expandable intraocular lens that fits within the natural lens compartment of the eye to eliminate the need for corrective lenses. The company is headquartered in Calgary, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Ocumetics Technology Corp., and the rating behind it. OTCFF last traded at $0.30; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Ocumetics Technology Corp.. Starting points for Ocumetics Technology Corp.: EPS -$0.06, beta 0.50 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Ocumetics Technology Corp.. Ocumetics Technology Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Ocumetics Technology Corp.. Trailing twelve-month EPS for Ocumetics Technology Corp. stands at -$0.06. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Ocumetics Technology Corp.. Ocumetics Technology Corp. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Ocumetics Technology Corp. valued side by side against its closest peers. Ocumetics Technology Corp. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Ocumetics Technology Corp., and how their positions are changing. At a $16.0M market value, institutional positions materially move Ocumetics Technology Corp.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Ocumetics Technology Corp. executives and directors. Shares of Ocumetics Technology Corp. have traded between $0.19 and $1.40 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Ocumetics Technology Corp.. Ocumetics Technology Corp. is a $16.0M Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Ocumetics Technology Corp.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Ocumetics Technology Corp.. Coverage tracks Ocumetics Technology Corp. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.